NBY - Bathi sadurunge bunga, pajak, lan amortisasi novabay.com

NovaBay Pharmaceuticals generates revenue through the sale of the antimicrobial agent Avenova and related eyelid products. The company's consolidated EBITDA reflects cash flow dynamics, with the value fixed at 0.00. The business is currently focusing on organic growth via online retail while divesting non-core assets. However, pricing pressure in the over-the-counter segment and the risk of losing customer loyalty pose threats to revenue.

Bathi sadurunge mbayar bunga, pajak, lan amortisasi: novabay.com (NBY) kanggo 23.11.2025 - 18.04.2026

NovaBay - rincian analitis lan metrik utama (NBY)

- nilai pasar lan prakiraan target analis:

Rega bursa NovaBay|NBY - Prakiraan konsensus analis

- statistik kapitalisasi pasar:

Nilai pasar NovaBay Pharmaceuticals Inc.|NBY - Nilai Total Perusahaan

- data kapitalisasi buku:

Aset Bersih saben Saham NovaBay Pharmaceuticals|NBY - Nilai Buku Perusahaan|Rasio Kapitalisasi marang Nilai Buku novabay.com|NBY - Aset Agregat Perusahaan

- data tingkat utang lan likuiditas finansial:

Utang marang Modal NovaBay Pharmaceuticals|NBY - Rasio utang jangka dawa marang ekuitas|Utang jangka cendhak marang ekuitas NovaBay|NBY - Gunggung utang perusahaan|Utang-utang marang kapitalisasi buku NovaBay Pharmaceuticals, Inc.|NBY - Utang jangka dawa perusahaan|Utang jangka cendhak perusahaan NovaBay Pharmaceuticals|Rasio cepet novabay.com

- indikator profitabilitas perusahaan lan kelipatan valuasi:

NBY - Penghasilan resik|Bathi resik sing dikarepake NovaBay Pharmaceuticals|NBY - Koefisien rega marang bathi|Pangali mangsa ngarep rega marang bathi NovaBay Pharmaceuticals|NBY - Rasio rega marang bathi tumrap wutah|Rasio nilai perusahaan marang bathi operasional sadurunge panyusutan NovaBay Pharmaceuticals, Inc.|NBY - Bathi operasional EBITDA|Bathi saben saham sajroning taun lumaku NovaBay Pharmaceuticals|NBY - Bathi resik saben saham (EPS TTM)|Wutah bathi EPS kuartalan novabay.com|NBY - Wutah bathi saben saham ing taun lumaku|Dinamika bathi saben saham sing diarepake ing taun ngarep NovaBay Pharmaceuticals

- data dodolan lan asil:

NBY - Pendapatan perusahaan|Volume dodolan mangsa ngarep perusahaan NovaBay|NBY - Multiplikator P/S|Multiplikator Forward P/S NovaBay Pharmaceuticals, Inc.

Ringkesan analitik perusahaan:NBY (novabay.com)

Produk asil prodhuksi NovaBay Pharmaceuticals Inc.

This indicator measures net cash flow from operating activities before depreciation and debt service costs, allowing investors to assess the business's fundamental ability to generate cash. An analysis of the overall EBITDA of NovaBay Pharmaceuticals (NBY) reveals the sensitivity of earnings to rising marketing expenses, which NovaBay Pharmaceuticals requires to protect its market position amid intense pressure from generic manufacturers.

Karo sapa NovaBay Pharmaceuticals saingan